Literature DB >> 18469815

Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model.

Kimberly L Stark1, Bin Xu, Anindya Bagchi, Wen-Sung Lai, Hui Liu, Ruby Hsu, Xiang Wan, Paul Pavlidis, Alea A Mills, Maria Karayiorgou, Joseph A Gogos.   

Abstract

Individuals with 22q11.2 microdeletions show behavioral and cognitive deficits and are at high risk of developing schizophrenia. We analyzed an engineered mouse strain carrying a chromosomal deficiency spanning a segment syntenic to the human 22q11.2 locus. We uncovered a previously unknown alteration in the biogenesis of microRNAs (miRNAs) and identified a subset of brain miRNAs affected by the microdeletion. We provide evidence that the abnormal miRNA biogenesis emerges because of haploinsufficiency of the Dgcr8 gene, which encodes an RNA-binding moiety of the 'microprocessor' complex and contributes to the behavioral and neuronal deficits associated with the 22q11.2 microdeletion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18469815     DOI: 10.1038/ng.138

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  294 in total

Review 1.  MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.

Authors:  Andrea de Bartolomeis; Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

2.  Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion.

Authors:  Liam J Drew; Kimberly L Stark; Karine Fénelon; Maria Karayiorgou; Amy B Macdermott; Joseph A Gogos
Journal:  Mol Cell Neurosci       Date:  2011-05-24       Impact factor: 4.314

3.  Transgenic mice overexpressing the extracellular domain of NCAM are impaired in working memory and cortical plasticity.

Authors:  Leann H Brennaman; Gaga Kochlamazashvili; Luminita Stoenica; Randall J Nonneman; Sheryl S Moy; Melitta Schachner; Alexander Dityatev; Patricia F Maness
Journal:  Neurobiol Dis       Date:  2011-04-16       Impact factor: 5.996

Review 4.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

Review 5.  Functions of noncoding RNAs in neural development and neurological diseases.

Authors:  Shan Bian; Tao Sun
Journal:  Mol Neurobiol       Date:  2011-10-04       Impact factor: 5.590

6.  Impaired hippocampal place cell dynamics in a mouse model of the 22q11.2 deletion.

Authors:  Jeffrey D Zaremba; Anastasia Diamantopoulou; Nathan B Danielson; Andres D Grosmark; Patrick W Kaifosh; John C Bowler; Zhenrui Liao; Fraser T Sparks; Joseph A Gogos; Attila Losonczy
Journal:  Nat Neurosci       Date:  2017-09-04       Impact factor: 24.884

Review 7.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

Review 8.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

9.  Cognitive ability is associated with altered medial frontal cortical circuits in the LgDel mouse model of 22q11.2DS.

Authors:  D W Meechan; H L H Rutz; M S Fralish; T M Maynard; L A Rothblat; A-S LaMantia
Journal:  Cereb Cortex       Date:  2013-11-11       Impact factor: 5.357

Review 10.  The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p.

Authors:  Gianluca Serafini; Maurizio Pompili; Katelin F Hansen; Karl Obrietan; Yogesh Dwivedi; Noam Shomron; Paolo Girardi
Journal:  Cell Mol Neurobiol       Date:  2013-11-09       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.